NCT01412450

Efficacity Study With the Protégé EverFlex Stent in Popliteal Lesions

DURABILITY-POP Study - Physician Initiated Trial Investigating the Efficacy of the Implant of Protégé EverFlex Nitinol Stents in Popliteal Lesions

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Flanders Medical Research Program · Network
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will assess the results up to 12 months with the Protégé EverFlex stent (ev3) in patients presenting with a narrowing or blocking at the level of the knee artery, which leads to a limited walking distance, rest pain or non-healing ulcers.

Conditions

• Peripheral Arterial Disease

Interventions

Type	Name	Description
DEVICE	nitinol stent	implantation of one Protégé EverFlex stent

Timeline

• Start date: 2010-07-01
• Primary completion: 2012-08-01
• Completion: 2012-08-01
• First posted: 2011-08-09
• Last updated: 2013-10-01

Locations

4 sites across 1 country: Belgium